The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...

The nationally recognized law firm Baron & Budd is pleased to announce that six of the firm's shareholders have been selected to the 2025 edition of the Lawdragon 500 Leading Lawyers in America.

Fluoride helps prevent cavities when applied topically to the teeth, but when ingested can pose significant risks, even kill ...

Other challenged products include Perrigo's Firefly anti-cavity rinse and Sanofi's Kids rinse ... v Colgate-Palmolive Co, U.S. District Court, Northern District of California, No. 25-00426; and Miller ...